Equipment has been developed for the automatic infusion of oxytocin using a positive pressure peristaltic pump. The automatic setting starts the infusion at 1 milliunit of oxytocin per minute and doubles the dose every 12.5 minutes. When contractions are of adequate strength and frequency, the "manual" control is used to maintain the oxytocin dose rate, and for immediate and accurate adjustment to any required level. Using this equipment in a series of 130 cases, the average induction-delivery interval was less than 8 hours. Continuous records of amniotic fluid pressure and fetal electrocardiography showed normal uterine contractions and fetal heart rate patterns.

A method of anaesthesia for the repair of bronchopleural fistula, based on that described by Dennison and Lester (1961) but with certain modifications, is presented, together with the results of a series of ten patients (11 operations) so managed. By using general anaesthesia as described, from the commencement, avoiding the use of muscle relaxants until the patient is safely positioned on the operating table, and by ensuring that spontaneous respiration is maintained during this period, it has been possible safely to dispense with the necessity for intubation of the conscious patient under topical analgesia. Furthermore, this method (in which the hazard from contamination of healthy lung tissue by spill-over of infected pleural fluid is not increased) has the advantage of being much less unpleasant for the patient. The anaesthetic technique for the repair of nervous and weary of "interference". To quote bronchopleural fistula used by ourselves until recently was that advocated by Dennison and Lester (1961). The main considerations of their technique are those of safety for the patient. To this end, endobronchial intubation is performed under topical analgesia, (a) in order to minimize the risk of soiling the contralateral lung, and the residue of lung (if any) on the side of the operation, and (b) by avoiding the use of general anaesthesia and muscle relaxants, to preserve spontaneous respiration-thus preventing the development of a tension pneumothorax which might be produced by positive pressure ventilation. The aim of our method, which follows very closely that advocated above, is to retain the safety of the technique but at the same time make the procedure less unpleasant for the patient. Many of these patients who develop a bronchopleural fistula following lung resection for carcinoma are ill. By the time they present at the anaesthetic room for the repair operation, they will already have been subjected to various procedures in the ward, such as bronchoscopy, aspiration of pleural fluid, insertion of intercostal drain, physiotherapy, and X-ray examination; they are therefore often

As the twenty-first century continues to bear witness to technological advancements, so our workplace will be changed increasingly by technology and the digital world. In this article, we try to explain the view of young Europeans on this inevitable process, the workplace that is changing. After all, the majority of the people who have to work in this new and modern workplace are the young Europeans themselves. We can conclude that young Europeans are aware of and feel part of this digitisation process. However, they still consider human contact to be a vital aspect of the relationships between employees and employers. Moreover, there is a belief that traineeships and internships help young Europeans to better develop their skills and adapt to the new workplace. Due to technological advancements, the workplace is changing in several ways. The differences between work and home can sometimes become blurred, but for many young Europeans it remains very important to be able to distinguish between home and the workplace.

The Process and Environmental Monitoring Methods Working Group, composed of members from industry and instrument manufacturers, met with the FDA Emerging Technology Team to discuss bio-fluorescent particle counting technology, a type of rapid microbiological method. This is a summary of the meeting including submitted questions and answers, and the Process and Environmental Monitoring Methods Working Group's understanding of the FDA Emerging Technology Team's points made.